Search
forResearch 10 of 657
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- 1318 Both lesional and non-lesional skin from acne patients shows robust IL-17-skewing and upregulation of antimicrobial peptides
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →